(VIANEWS) – Shares of Illumina (NASDAQ: ILMN) rose 8.03% to $201.84 at 11:56 EST on Wednesday, following the last session’s upward trend. NASDAQ is jumping 0.62% to $10,896.74, following the last session’s upward trend. This seems, up to now, a somewhat positive trend exchanging session today.
Illumina’s last close was $186.84, 56.66% under its 52-week high of $431.11.
Illumina, Inc. offers array-based and sequencing solutions for genomic and genetic analysis. Illumina’s services and products are available to customers across a variety of markets. They enable the use of genomic solutions for research and clinical applications. These include the areas of life science, oncology and reproductive health. It offers consumables and instruments for genetic analysis, genotyping, sequencing, contract service contracts, development and licensing agreements as well as services in cancer detection and testing. Customers include academic and government institutions as well as hospitals and pharmaceutical and biotechnology companies. It sells directly to its customers in North America and Europe as well as Latin America and the Asia-Pacific. It was founded in 1998 in San Diego, California.
Earnings Per Share
As for profitability, Illumina has a trailing twelve months EPS of $4.28.
Illumina has a trailing twelve months price to earnings ratio of 47.16. Meaning,
the purchaser of the share is investing $47.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.86%.
Illumina’s value is below its 50-day moving average of $206.88 and way under its 200-day moving average of $281.64.
Today’s last reported volume for Illumina is 1323033 which is 9.02% below its average volume of 1454230.
Illumina’s sales growth for the next quarter is 19.8%.
More news about Illumina (ILMN).